Fibrocell Science Inc (FCSC)

[exwannabe]

I like the ramp up in the factory personnel. ...

Maybe, but let us run the numbers some more.

They are on record (I believe) in saying that the current facilities can handle 5k sales over the next 18 months. Let us assume these are enough employees to handle the task, and further they could do 5k in a year.

How many employees? Let us go with 50. Obviously some who were hired are not going to scale with size, but they also had some on board. They already had on all the high level people that were needed to get the plant past FDA.

So we have 50 employees generating about $12.5M of revenue. These are not burger slapers, so assume they cost $150k/y (employees cost is much more than salary).

Biotech manufacturing is not generally a labour intensive business. Yet we have half the revenue already allocated there.

There are certainly plenty of arguments that can be made against this post, but I could make stronger arguments on my side also. One has to admit that the cost of sales issue is in play.

I do think this stuff could sell. Hell, botox is completely absurd and it sells. Never underestimate vanity and greed.

But until the company makes some serious effort to address the finacials I doubt you will see much of a PPS boost.